27 Sep, 2022 RNAi Roundtable: Cemdisiran, in Development for the Treatment of IgA Nephropathy (IgAN) and Other Complement-Mediated Diseases
Posted at 11:13h
in Capella
On September 27, 2022, we hosted an online RNAi Roundtable to review the progress with cemdisiran, an investigational RNAi therapeutic in development for the treatment of IgA nephropathy (IgAN) and other complement-mediated diseases.
Access the replay
View the presentation
Eric Green
Senior Vice President, Development Programs
Sonalee Agarwal, Ph.D.
Vice President and Program Leader, Cemdisiran
Jonathan Barratt, Ph.D., FRCP
The Mayer Professor of Renal Medicine Department of Cardiovascular Sciences; Honorary Consultant Nephrologist, The John Walls Renal Unit, Leicester General Hospital
Ishir Bhan, M.D., MPH
Senior Director, Clinical Research
